ASPN at a glance
ASPEN AEROGELS INC (ASPN, SEC CIK 1145986) filed its latest 10-K annual report on March 13, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as November 6, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), ASPEN AEROGELS INC (ASPN) reported revenue of $271.1 million (down 40.1% from FY2024) and a net loss of $389.6 million. Diluted EPS was -$4.73.
- As of September 30, 2026, 27 institutional investment managers tracked by SignalX reported holding ASPEN AEROGELS INC (ASPN) shares worth $149.6 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Wood River Capital, LLC on September 23, 2026 of 12,280,426 shares at $4.73 per share.
- In the last 90 days, ASPN insiders reported 0 open-market purchases ($0) and 1 open-market sale ($58.1M) on Form 4, a net sale of $58.1M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $271.1M
- −40.1% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$58.1M
- 13F holders
- 27 funds
- $149.6M · −2 vs prior quarter
- Latest 8-K
- Nov 5, 2026
- Item 2.02 · Item 5.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material risk-factor changes since the Annual Report, except disclosures in the March 31, 2026 Form 10-Q
- Carried-forward risks remain governed by the Annual Report’s Part I, Item 1A disclosures
- No new regulatory, operational, competitive, or financial risks identified in this filing
Management Discussion & Analysis
- Revenue $85.2M, up 17% YoY from $73.0M, driven by Energy Industrial growth
- Gross margin 24% vs 28% YoY, with net loss $10.4M vs $6.3M
- Best segment Energy Industrial: revenue $39.9M, up 64%; gross margin 39% vs 36%
- Worst segment Thermal Barrier: revenue $45.3M, down 7%; gross margin 11% vs 24%
- Cash $146.0M, operating cash flow $14.2M; $27.3M financing outflow, including $19.5M term-loan repayment
AI summary of the ASPN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 2026 results announced for quarter ended September 30, 2026
- Business developments included in accompanying Exhibit 99.1 press release
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Stacy D. Nieuwoudt appointed independent Class III director effective November 4, 2026, expanding the Board from six to seven members
- Added to Audit and Compensation & Leadership Development Committees, strengthening energy-sector and capital-markets expertise
Item 7.01: Regulation FD Disclosure
- Item 7.01 incorporates Aspen Aerogels’ press-release financial outlook into the company’s public disclosure
- Investors should review the referenced “Financial Outlook” section for management’s current expectations and market guidance
Item EX-99.2: Item EX-99.2
- Stacy Nieuwoudt appointed director effective November 4, 2026
- Board adds energy-sector and asset-management expertise from Citadel-affiliated firms
Item EX-99.1: Item EX-99.1
- Q3 revenue $85.2M, up 17% YoY and 71% QoQ, led by Energy Industrial revenue growth to $39.9M
- Adjusted EBITDA $19.8M, or 23% margin, versus $6.3M and 9% YoY, despite $15.1M East Providence incident costs
Item 7.01: Regulation FD Disclosure
- Aspen Aerogels posted an investor presentation on September 15, 2026, for use in investor and analyst discussions
- Presentation contents represent management’s investor messaging and outlook; investors should review Exhibit 99.1 for substantive details
Item 7.01: Regulation FD Disclosure
- Item 7.01 incorporates the press release’s “Financial Outlook” and company description into the disclosure record
- Investors should review the referenced exhibit for Aspen Aerogels’ latest outlook and operating expectations
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results announced for quarter ended June 30, 2026
- Business developments discussed alongside quarterly financial results
Item EX-99.1: Item EX-99.1
- Q2 revenue $49.8M, down from $78.0M, with Thermal Barrier revenue $29.5M, down 47% year over year
- Adjusted EBITDA $(6.6)M versus $9.7M, reflecting $5.3M of East Providence incident-related costs
AI summaries of ASPN 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ASPN
Don't miss the next ASPN filing
- Alerts as it files. A push when ASPN files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ASPN, by share count.
- Ask anything. An AI agent that reads every ASPN filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Nieuwoudt Stacy Durbin | A | Nov 4, 2026 | 5,100 | - |
| Nieuwoudt Stacy Durbin | A | Nov 4, 2026 | 6,073 | - |
| DEEGAN GLENN E. | F | Sep 30, 2026 | 1,143 | $5.48 |
| Wood River Capital, LLC | Sell | Sep 23, 2026 | 12,280,426 | $4.73 |
| NOGLOWS WILLIAM P | M | Jun 23, 2026 | 14,799 | - |
| NOGLOWS WILLIAM P | M | Jun 23, 2026 | 14,799 | $4.75 |
| Mitchell Steven R | A | May 13, 2026 | 10,370 | - |
| NOGLOWS WILLIAM P | A | May 13, 2026 | 8,706 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $452.7M | $271.1M |
| Gross Profit | - | $182.9M | $46.0M |
| Operating Income | - | $54.5M | -$378.2M |
| Net Income | - | $13.4M | -$389.6M |
| Gross Margin | - | 40.4% | 17.0% |
| Op. Margin | - | 12.0% | -139.5% |
| Net Margin | - | 3.0% | -143.7% |
| Balance Sheet | |||
| Total Assets | $703.0M | $895.1M | $406.7M |
| Equity | - | $614.7M | $235.5M |
| ROE | - | 2.2% | -165.4% |
| Per Share | |||
| EPS | - | $0.17 | $-4.73 |
| Cash Flow | |||
| Operating CF | - | $45.5M | $32.9M |
| CapEx | $175.5M | $86.3M | $37.4M |
Source: XBRL data in ASPEN AEROGELS INC (ASPN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate ASPN share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 27 | $149.6M |
| Q2 2026 | 29 | $166.4M |
| Q1 2026 | 27 | $80.2M |
| Q4 2025 | 24 | $79.2M |
| Q3 2025 | 25 | $180.6M |
| Q2 2025 | 26 | $143.6M |
| Q1 2025 | 24 | $121.8M |
| Q4 2024 | 17 | $184.0M |
- Citadel Advisors LLC+771.1K (+323%)
- AQR Capital Management+618.2K (+48%)
- Dimensional Fund Advisors+588.9K (+41%)
- Morgan Stanley+441.2K (+111%)
- Bank of America Corp+179.9K (+71%)
- Invesco Ltd−473.1K (-29%)
- Goldman Sachs Group−243.8K (-18%)
- Renaissance Technologies LLC−226.2K (-82%)
- Prudential Financial−218.8K (-95%)
- Millennium Management−194.9K (-16%)
- FMR LLC (Fidelity)−68.5K
- Equitable Holdings Inc−13.8K
Source: 13F-HR filings on SEC EDGAR (aggregated from 199 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ASPN filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 6, 2026 | - | - | - |
| 10-Q | Nov 5, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 5, 2026 | - | Analysis | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 8-K | Sep 15, 2026 | - | Analysis | - |
| 10-Q | Aug 7, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 4 | Jun 26, 2026 | - | - | - |
| 8-K | May 18, 2026 | - | Analysis | |
| 4 | May 14, 2026 | - | - | |
| 4 | May 14, 2026 | - | - | |
| 4 | May 14, 2026 | - | - | |
| 4 | May 14, 2026 | - | - | |
| 4 | May 14, 2026 | - | - | |
| 10-Q | May 8, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 7, 2026 | - | Analysis | |
| 8-K | Apr 21, 2026 | - | Analysis | - |
| 10-K | Mar 13, 2026 | Dec 31, 2025 | - | |
| 4 | Mar 10, 2026 | - | - | - |
| 4 | Mar 10, 2026 | - | - | - |
| 4 | Mar 10, 2026 | - | - | - |
| 4 | Mar 10, 2026 | - | - | - |
| 4 | Mar 6, 2026 | - | - | - |
| 4 | Mar 6, 2026 | - | - | - |
Related Consumer Discretionary companies
- BCC · BOISE CASCADE CoWholesale-Lumber & Other Construction Materials
- FLWS · 1 800 FLOWERS COM INCRetail-Retail Stores, NEC
- ANF · ABERCROMBIE & FITCH CO /DE/Retail-Family Clothing Stores
- ASO · Academy Sports & Outdoors, Inc.Retail-Miscellaneous Shopping Goods Stores
- GOLF · Acushnet Holdings Corp.Sporting & Athletic Goods, NEC
- ADNT · Adient plcMotor Vehicle Parts & Accessories
- AAP · ADVANCE AUTO PARTS INCRetail-Auto & Home Supply Stores
- ASLE · AerSale CorpWholesale-Machinery, Equipment & Supplies
ASPN SEC filings: frequently asked questions
Are ASPN insiders buying or selling?
In the last 90 days, ASPEN AEROGELS INC (ASPN) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $58.1 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold ASPN stock?
As of September 30, 2026, the largest ASPEN AEROGELS INC (ASPN) holders among the 13F filers tracked by SignalX were BlackRock ($29.1 million), Vanguard Capital Management LLC ($19.4 million), State Street Corp ($14.0 million), Dimensional Fund Advisors ($11.2 million), AQR Capital Management ($10.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ASPN's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), ASPEN AEROGELS INC (ASPN) reported revenue of $271.1 million (down 40.1% from FY2024) and a net loss of $389.6 million. Diluted EPS was -$4.73. The figures come from the XBRL data in the 10-K.
What did ASPN report in its latest 8-K?
ASPEN AEROGELS INC (ASPN) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Appointment of Directors or Principal Officers) and Item 7.01 (Regulation FD Disclosure). Q3 2026 results announced for quarter ended September 30, 2026.
What are the latest ASPN SEC filings?
ASPEN AEROGELS INC (ASPN) filed its latest 10-K annual report on March 13, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on November 6, 2026.
What is ASPN's SEC CIK number?
ASPEN AEROGELS INC (ASPN)'s SEC Central Index Key (CIK) is 1145986. EDGAR lists every ASPN filing under that number.
Ask anything about ASPN
The research agent reads ASPN's filings, financials, insider trades and 13F holders, then answers with sources.